|
Market Closed -
OTC Markets
09:59:54 2026-06-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.005000 USD | -13.79% |
|
-.--% | -37.11% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||
Medical Devices | 3.21M | 3.26M | 3.54M | 3.15M | - | |||
Total Assets | 7.73M | 6.59M | 5.9M | 4.89M | - | |||
Income Tax Expense | - | - | - | - | - | |||
EBT | -1.75M | -1.12M | -838K | -757K | - | |||
D&A | 1.31M | 1.16M | 998K | 865K | - | |||
Net Income | -1.75M | -1.12M | -838K | -757K | - | |||
Net Income | 2.56M | -5.71M | -3.04M | -1.36M | - | |||
EBT | 2.56M | -5.71M | -3.04M | -1.36M | - | |||
Pharmaceutical Products | ||||||||
Prescription Medications | 4.61M | 2.73M | 2.29M | 1.96M | - | |||
Total Assets | 59.66M | 25.83M | 27.89M | 5.74M | - | |||
EBT | -9.8M | -13.2M | -4.28M | -12.2M | - | |||
D&A | 5.56M | 4.44M | 2.29M | 1.97M | - | |||
Net Income | -9.8M | -13.2M | -4.28M | -12.2M | - | |||
Total Assets | - | - | - | - | 5.16M | |||
EBT | - | - | - | - | -4.5M | |||
Operating Income | - | - | - | - | -4.64M | |||
Net Income | - | - | - | - | 1.91M |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
International | 1.24M | 1.19M | 1.3M | 1.07M | - | |||
United States | 6.57M | 4.8M | 4.53M | 4.04M | - |
- Stock Market
- Stocks
- PTPI Stock
- Financials Petros Pharmaceuticals
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
